IDH2 Inhibitor for AML is Effective with RR Disease - Differentiation syndrome is a worrying side-effect - 100459

Spotlight
Video

IDH2 Inhibitor for AML is Effective with RR Disease - Differentiation syndrome is a worrying side-effect

moasc has 313 videos Subscribe Here

Loading........
Description: Deepa Jeyakumar, MD, from UC Irvine Health discusses how IDH2 inhibitor for AML is effective with Relapsed Refractory disease and the differentiation syndrome is a worrying side-effect all at MOASC’s Spotlight On® Hematology in Huntington Beach.
Shared By : moasc
Posted on : 02/01/18
Added : 7 months ago